-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Prostate Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Prostate Cancer Drug Details: AGENT-797 is under development for the treatment of moderate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Solid Tumor Drug Details: AGENT-797 is under development for the treatment of moderate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Pancreatic Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Pancreatic Cancer Drug Details: AGENT-797 is under development for the treatment of moderate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Gastric Cancer Drug Details: AGENT-797 is under development for the treatment of moderate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Hepatocellular Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Hepatocellular Carcinoma Drug Details: AGENT-797 is under development for the treatment of moderate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Rectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Rectal Cancer Drug Details: AGENT-797 is under development for the treatment of moderate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Testicular Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Testicular Cancer Drug Details: AGENT-797 is under development for the treatment of moderate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Colorectal Cancer Drug Details: AGENT-797 is under development for the treatment of moderate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Cervical Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Cervical Cancer Drug Details: AGENT-797 is under development for the treatment of moderate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Duodenal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Duodenal Cancer Drug Details: AGENT-797 is under development for the treatment of moderate...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.